Smiths Group Q1 Trading Statement

RNS Number : 3500F

Smiths Group PLC

16 November 2020

 

 

 

 

News Release

London , 16 November 2020

For immediate release

Smiths Group Q1 Trading Statement

Smiths Group plc ("Smiths" or "the Group") today announces its trading statement for the first quarter of FY2021. 

Smiths delivered a good trading performance in the first quarter. In a period of ongoing global disruption, the Group continues to demonstrate its resilience, founded on market-leading positions and a high proportion of aftermarket revenues.

Revenue for the three months ended 31 October for Continuing Operations¹ was down (2)% on an underlying² basis. This underpins the Group's confidence in meeting market expectations for the full year.

· John Crane performed as expected, with challenging market conditions in Energy, partially offset by modest growth in Industrials

· Smiths Detection delivered a strong performance in Aviation during the quarter, driven by delivery of original equipment orders, which was offset by Other Security Systems

· Flex-Tek delivered strong Industrial sales that more than offset Aerospace weakness

· Good momentum continued in Smiths Interconnect

Revenue for the three months ended 31 October for Smiths Medical¹ was up 4% on an underlying² basis driven by further growth in Infusion Systems and Vital Care.

The Group's strategic restructuring programme is progressing well and will deliver the anticipated £30m of savings in the current year and the full £70m benefit in FY2022.

The Group continues to demonstrate its strong cash generation and cash balances at 31 October had increased to £413m.

On 27 October 2020, the Trustee of the Smiths Industries Pension Scheme secured a further £146.5m bulk annuity buy-in agreement with Canada Life, which insured the benefits of a further c.1,000 pensioners, demonstrating further progress in the de-risking of the Company's pension liabilities.

¹ Continuing Operations exclude Smiths Medical which is accounted for as 'Discontinued Operations - businesses held for  distribution to owners', given the intended   separation of Smiths Medical.

² Underlying modifies headline performance to exclude the effects of foreign exchange.

END

Investor enquiries	Media enquiries
Jemma Spalton, Smiths Group [phone] [e-mail]	Richard Mountain, FTI Consulting [phone] [e-mail]	Alex Le May, FTI Consulting [phone] [e-mail]

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

About Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). Its businesses share common characteristics (well-positioned in growing markets, technology-led, asset-light, digitising, with a high proportion of aftermarket revenues) and a common operating model (The Smiths Excellence System). For more information visit www.smiths.com .

 

END

 

 

TSTEANFSFFEEFFA